Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4306
Gene Symbol: NR3C2
NR3C2
0.010 GeneticVariation disease BEFREE This study aims to assess the comparative benefit and risk profile of treatment with mineralocorticoid receptor antagonists (MRAs) with regard to all-cause mortality (primary endpoint), cardiovascular mortality, or heart failure (HF)-related hospitalization (secondary endpoints) and the safety endpoints hyperkalemia, acute renal failure, and gynecomastia in patients with chronic HF. 31364027 2020
Entrez Id: 51014
Gene Symbol: TMED7
TMED7
0.010 Biomarker disease BEFREE Statistically significant positive correlations between GT and ASPS data were as follows: breast lift: "mastopexy" (R = 0.445, P = 0.025); male breast reduction: "gynecomastia surgery" (R = 0.45, P = 0.024); and breast reconstruction: "tissue expander" (R = 0.806, P ≤ 0.001) and "TRAM flap reconstruction" (R = 0.764, P = 0.002). 30870175 2019
Entrez Id: 23471
Gene Symbol: TRAM1
TRAM1
0.010 Biomarker disease BEFREE Statistically significant positive correlations between GT and ASPS data were as follows: breast lift: "mastopexy" (R = 0.445, P = 0.025); male breast reduction: "gynecomastia surgery" (R = 0.45, P = 0.024); and breast reconstruction: "tissue expander" (R = 0.806, P ≤ 0.001) and "TRAM flap reconstruction" (R = 0.764, P = 0.002). 30870175 2019
Entrez Id: 353376
Gene Symbol: TICAM2
TICAM2
0.010 Biomarker disease BEFREE Statistically significant positive correlations between GT and ASPS data were as follows: breast lift: "mastopexy" (R = 0.445, P = 0.025); male breast reduction: "gynecomastia surgery" (R = 0.45, P = 0.024); and breast reconstruction: "tissue expander" (R = 0.806, P ≤ 0.001) and "TRAM flap reconstruction" (R = 0.764, P = 0.002). 30870175 2019
Entrez Id: 100302736
Gene Symbol: TMED7-TICAM2
TMED7-TICAM2
0.010 Biomarker disease BEFREE Statistically significant positive correlations between GT and ASPS data were as follows: breast lift: "mastopexy" (R = 0.445, P = 0.025); male breast reduction: "gynecomastia surgery" (R = 0.45, P = 0.024); and breast reconstruction: "tissue expander" (R = 0.806, P ≤ 0.001) and "TRAM flap reconstruction" (R = 0.764, P = 0.002). 30870175 2019
Entrez Id: 5241
Gene Symbol: PGR
PGR
0.010 AlteredExpression disease BEFREE High digit ratio in men with gynecomastia may tend to be a marker of overexpression of ER and PR. 29772574 2018
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.010 Biomarker disease BEFREE This report highlights that a focal F-FDG uptake in the testicular region with unexplained gynecomastia should suggest the diagnosis of an estrogen-secreting Leydig cell tumor on F-FDG PET/CT. 29166332 2018
Entrez Id: 181
Gene Symbol: AGRP
AGRP
0.010 Biomarker disease BEFREE The burden of gynecomastia among men on ART in Malawi was higher than previously reported, and was associated with adverse psychological consequences, calling for increased awareness, a proactive diagnostic approach and diligent clinical management. 29155891 2017
Entrez Id: 2346
Gene Symbol: FOLH1
FOLH1
0.010 AlteredExpression disease BEFREE Abnormal concentration of Ga-PSMA in breast cancer is now well known, and in this context, it is important to know that tracer localization can occur in gynecomastia as well, as evidenced in this case. 28682848 2017
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.010 Biomarker disease BEFREE The burden of gynecomastia among men on ART in Malawi was higher than previously reported, and was associated with adverse psychological consequences, calling for increased awareness, a proactive diagnostic approach and diligent clinical management. 29155891 2017
Entrez Id: 2852
Gene Symbol: GPER1
GPER1
0.010 GeneticVariation disease BEFREE The aim of this study was to evaluate the association between GPR30 single nucleotide polymorphisms and gynecomastia in males. 25531203 2015
Entrez Id: 2100
Gene Symbol: ESR2
ESR2
0.010 GeneticVariation disease BEFREE According to our results, increased E2 level and ER beta gene rs4986938 polymorphism might explain why some adolescents have gynecomastia. 24625355 2014
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.010 Biomarker disease BEFREE To further support the microarray data, an immunohistochemical analysis for two specific miRNA gene targets (HOXD10 and VEGF) was performed in a small series of male breast carcinoma and gynecomastia samples. 19664288 2009
Entrez Id: 3236
Gene Symbol: HOXD10
HOXD10
0.010 Biomarker disease BEFREE To further support the microarray data, an immunohistochemical analysis for two specific miRNA gene targets (HOXD10 and VEGF) was performed in a small series of male breast carcinoma and gynecomastia samples. 19664288 2009
Entrez Id: 260402
Gene Symbol: IS1
IS1
0.010 GeneticVariation disease BEFREE In the family with AR I737T, sex phenotype varied from severely defective masculinization in the proband to a maternal great uncle whose only manifestation of AIS was severe gynecomastia. 15541764 2005
Entrez Id: 8626
Gene Symbol: TP63
TP63
0.010 GeneticVariation disease BEFREE In the family with AR I737T, sex phenotype varied from severely defective masculinization in the proband to a maternal great uncle whose only manifestation of AIS was severe gynecomastia. 15541764 2005
Entrez Id: 55010
Gene Symbol: PARPBP
PARPBP
0.010 Biomarker disease BEFREE AROM+ mice present several dysfunctions, such as adrenal and pituitary hyperplasia, cryptorchidism, Leydig cell hypertrophy and hyperplasia, and gynecomastia. 14982857 2004
Entrez Id: 3973
Gene Symbol: LHCGR
LHCGR
0.010 AlteredExpression disease LHGDN Presence of luteinizing hormone/human chorionic gonadotropin receptors in male breast tissues. 15292356 2004
Entrez Id: 3815
Gene Symbol: KIT
KIT
0.010 Biomarker disease BEFREE The localization of c-kit protein was examined immunohistochemically in human breast, consisting of 366 normal tissue, 156 benign lesions (fibroadenoma, fibrocystic change, intraductal papilloma, benign phyllodes tumor, and gynecomastia), 13 borderline diseases (atypical ductal hyperplasia, atypical lobular hyperplasia, and borderline malignant phyllodes tumor), and 197 malignant lesions (non-invasive and/or invasive ductal carcinoma and malignant phyllodes tumor). 12029439 2002
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.010 GeneticVariation disease BEFREE We report on a 10-year-old boy with moderate mental retardation, hypotonia, obesity and gynaecomastia and a de novo 2-bp deletion in the MECP2 gene that resulted in a frameshift and premature stop codon. 12081720 2002
Entrez Id: 10085
Gene Symbol: EDIL3
EDIL3
0.010 Biomarker disease BEFREE The other gynecomastia presented del(1)(q41) as detected by both cytogenetic and CGH analysis. 12034524 2002
Entrez Id: 1576
Gene Symbol: CYP3A4
CYP3A4
0.010 Biomarker disease BEFREE Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase. 11067738 2000
Entrez Id: 6462
Gene Symbol: SHBG
SHBG
0.010 AlteredExpression disease BEFREE Two adult brothers, referred because of gynecomastia and hormonal levels in serum indicating androgen insensitivity (high sex hormone-binding globulin, and LH levels, despite extremely high testosterone concentration), turned out to be relatives to a third young man, referred independently of the two others and exhibiting identical clinical and hormonal stigmata. 10852459 2000
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.010 GeneticVariation disease BEFREE To determine the contribution of BRCA1 and BRCA2 mutations to the pathogenesis of male breast cancer in Hungary, the country with the highest male breast cancer mortality rates in continental Europe, a series of 18 male breast cancer patients and three patients with gynecomastia was analyzed for germ-line mutations in both BRCA1 and BRCA2. 10070953 1999
Entrez Id: 1081
Gene Symbol: CGA
CGA
0.020 Biomarker disease BEFREE • CT breast glandular tissue diameter correlates with log(b-HCG) • Gynaecomastia in CT is associated with worse prognosis • Gynaecomastia in CT is associated with non-seminoma histological subtype. 27229339 2017